Antibiotic compositions that modulate microbial quorum sensing to control bacterial infections and biofilms

This technology uses AI-2 analog compounds to control bacterial communication, helping prevent or treat infections and reduce biofilm formation.

Background

Bacterial infections and the formation of biofilms pose significant challenges in healthcare and various industrial settings. Bacteria often coordinate their behavior through a sophisticated communication system known as quorum sensing, which allows them to sense their population density and collectively regulate gene expression. This coordination is crucial for processes like virulence factor production, host colonization, and the formation of protective biofilms, making it a critical target for developing novel intervention strategies.

Current therapeutic approaches primarily rely on broad-spectrum antibiotics, which frequently face limitations due to rising antimicrobial resistance and their inability to effectively penetrate and eradicate established biofilms. These conventional treatments can also disrupt beneficial microbial communities, leading to dysbiosis and secondary infections. A significant challenge lies in developing targeted strategies that can disrupt bacterial pathogenicity without indiscriminately killing bacteria, thereby mitigating resistance development and preserving commensal microbiota.

Technology

This technology encompasses novel compositions and methods designed to regulate quorum sensing within various microbes, particularly bacteria. It employs specific chemical compounds, which are analogs of autoinducer-2 (AI-2), a critical signaling molecule essential for bacterial communication. These compounds possess structures similar to 4,5-dihydroxy-2,3-pentanedione and can either mimic or block natural AI-2 signals, functioning as agonists or antagonists of quorum sensing. This capability enables precise control over collective bacterial behaviors, making these compounds valuable for the prevention or treatment of bacterial infections and for reducing problematic biofilm formation.

What distinguishes this approach is its fundamental departure from conventional antimicrobial strategies. Rather than directly eliminating bacteria, which frequently accelerates the development of antibiotic resistance, this technology focuses on disrupting or modifying their intricate communication systems. By manipulating quorum sensing, these compounds can interfere with crucial processes such as the production of virulence factors, the release of toxins, or the formation of biofilms, without necessarily eradicating the bacterial population. This “anti-virulence” or “anti-biofilm” strategy offers a promising alternative for combating drug-resistant pathogens by disarming them, potentially mitigating the evolutionary pressure for resistance.

Benefits

  • Modulates bacterial quorum sensing to control microbial behavior
  • Acts as agonists or antagonists to regulate bacterial communication
  • Useful for preventing and treating bacterial infections
  • Helps reduce biofilm formation, improving infection management
  • Targets AI-2 signaling pathways, a common bacterial communication mechanism

Applications

  • Preventing bacterial biofilm formation
  • Treating antibiotic-resistant infections
  • Enhancing probiotic effectiveness
  • Protecting medical device surfaces

Additional info

Compositions and methods employ AI-2 analogs, structurally similar to 4,5-dihydroxy-2,3-pentanedione, to modulate microbial quorum sensing. These compounds function as agonists or antagonists, useful for bacterial infection prophylaxis, therapy, and biofilm reduction.

Publication

“Synthetic analogs tailor native AI-2 signaling across bacterial species.” Roy V, Smith JA, Wang J, Stewart JE, Bentley WE, Sintim HO. J Am Chem Soc. 2010 Aug 18;132(32):11141-50. doi: 10.1021/ja102587w. PMID: 20698680.